Jay Olson's Stock Ratings

Oppenheimer Analyst

Jay Olson is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

17.4%

Smart Score

69.9%

Overall Average Return Percentile

73rd

Number of Ratings

12
Buy NowGet Alert
12/15/2025PRAXBuy Now
Praxis Precision Medicine
$276.40171.35%$250 → $750MaintainsOutperformGet Alert
12/09/2025TERNBuy Now
Terns Pharma
$44.0131.79%$28 → $58MaintainsOutperformGet Alert
10/22/2025TERNBuy Now
Terns Pharma
$44.01-61.37%$20 → $17MaintainsOutperformGet Alert
10/21/2025IBIOBuy Now
iBio
$1.85170.86% → $5Initiates → OutperformGet Alert
08/04/2025MNMDBuy Now
Mind Medicine
$12.08106.95% → $25Reinstates → OutperformGet Alert
07/29/2025ATAIBuy Now
ATAI Life Sciences
$4.10241.46% → $14Initiates → OutperformGet Alert
07/08/2025PRAXBuy Now
Praxis Precision Medicine
$276.40-58.39%$97 → $115MaintainsOutperformGet Alert
06/02/2025PRAXBuy Now
Praxis Precision Medicine
$276.40-64.91% → $97Assumes → OutperformGet Alert
05/21/2025TVRDBuy Now
Tvardi Therapeutics
$4.501344.44% → $65Initiates → OutperformGet Alert
12/06/2024SGMTBuy Now
Sagimet Biosciences
$6.10391.8% → $30Initiates → OutperformGet Alert
12/04/2024TERNBuy Now
Terns Pharma
$44.01-54.56%$17 → $20MaintainsOutperformGet Alert
10/31/2024TERNBuy Now
Terns Pharma
$44.01-61.37% → $17Initiates → OutperformGet Alert